65 results
424B3
BTMD
biote Corp - Ordinary Shares
10 May 24
Prospectus supplement
4:12pm
using bio-identical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
On May 26, 2022 (the “Closing Date”), BioTE … on women experiencing symptoms due to hormonal imbalance before, during, and after menopause, and men experiencing symptoms of hypogonadism and male
424B3
BTMD
biote Corp - Ordinary Shares
10 May 24
Prospectus supplement
4:10pm
using bio-identical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
On May 26, 2022 (the “Closing Date”), BioTE … on women experiencing symptoms due to hormonal imbalance before, during, and after menopause, and men experiencing symptoms of hypogonadism and male
424B3
BTMD
biote Corp - Ordinary Shares
9 Apr 24
Prospectus supplement
4:28pm
and treatment options to address hormonal imbalances.
Patient symptoms associated with menopause in women and andropause in men, such as hot flashes, night … undergo testosterone treatment. An average of 27 million women between the ages of 45 and 64, or 20% of the American workforce, experience menopause every
424B3
va6wewfwv2rdo
9 Apr 24
Prospectus supplement
4:25pm
POS AM
fq515fqory36
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
POS AM
zm5oz 5s9w1ql
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
8-K
EX-99.1
v55gbr ho4
14 Mar 24
Regulation FD Disclosure
4:06pm
424B3
26aw0ru76cgngw0
13 Nov 23
Prospectus supplement
6:44pm
424B3
vl63wznlg6
13 Nov 23
Prospectus supplement
6:43pm
424B3
9wripa4
11 Aug 23
Prospectus supplement
3:55pm
424B3
bsqh y4k27yvcxcn5
11 Aug 23
Prospectus supplement
3:55pm
424B3
ikm8 w5frp8
7 Jun 23
Prospectus supplement
9:15am
S-4/A
7npt0ieavcpz
16 May 23
Registration of securities issued in business combination transactions (amended)
5:16pm
424B3
490b2jf12gjbhdrc
16 May 23
Prospectus supplement
8:32am